Sidney Ariel Schechet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sidney Ariel Schechet has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Seenu M. Hariprasad
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, 60637, United States of America
5 shared publications - Dimitra Skondra
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, United States
4 shared publications Michael J. Shapiro
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois; Retina Consultants, Ltd, Chicago, Illinois
3 shared publications- Michael P. Blair
Retina Consultants, Ltd, Des Plaines, Illinois
3 shared publications Darin T. Rosen
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois, United States of America
2 shared publicationsEva DeVience
University of Maryland Baltimore Washington Medical Center, Baltimore, Maryland
2 shared publications
Latest Publications
- Open Access
- 22 March 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (5) , 100772
Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1
- 22 March 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (5) , 100772
Open AccessPivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1
- Open Access
- 7 November 2024
- Published by Elsevier in AJO International
- Vol. 1 (4)
Evolving practice patterns of young retinal specialists: A five-year comparison of treatment and surgical preferences
- 7 November 2024
- Published by Elsevier in AJO International
- Vol. 1 (4)
Open AccessEvolving practice patterns of young retinal specialists: A five-year comparison of treatment and surgical preferences
- Open Access
- 29 August 2024
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 9 (1) , e001854
New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors
Current literature estimates that around 196 million people around the world have age-related macular degeneration (AMD), making AMD the leading cause of blindness in adults greater than 50 years of age in developed countries.1 Geographic atrophy (GA) is characterised by progressive degenerative lesions of the retina in the advanced stages of non-exudative AMD. These atrophic lesions are typically caused by the death of photoreceptors, retinal pigment epithelium (RPE) and choriocapillaris.2 Although the mechanism is not fully understood, the pathophysiology of GA is well documented to involve the complement system, where overactivation of complement components leads to opsonisation and induction of inflammatory cytokines, resulting in the destruction of the aforementioned structures.3 One of the hallmark features of exudative AMD is choroidal neovascularisation (CNV), characterised by abnormal growth and leakage of choroidal vasculature breaking through Bruch’s membrane, triggered by the activation of vascular endothelial growth factor (VEGF).4 Multiple therapies are available for exudative AMD, with intravitreal anti-VEGF drugs being the most widely used.5
- 29 August 2024
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 9 (1) , e001854
Open AccessNew horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors
Current literature estimates that around 196 million people around the world have age-related macular degeneration (AMD), making AMD the leading cause of blindness in adults greater than 50 years of age in developed countries.1 Geographic atrophy (GA) is characterised by progressive degenerative lesions of the retina in the advanced stages of non-exudative AMD. These atrophic lesions are typically caused by the death of photoreceptors, retinal pigment epithelium (RPE) and choriocapillaris.2 Although the mechanism is not fully understood, the pathophysiology of GA is well documented to involve the complement system, where overactivation of complement components leads to opsonisation and induction of inflammatory cytokines, resulting in the destruction of the aforementioned structures.3 One of the hallmark features of exudative AMD is choroidal neovascularisation (CNV), characterised by abnormal growth and leakage of choroidal vasculature breaking through Bruch’s membrane, triggered by the activation of vascular endothelial growth factor (VEGF).4 Multiple therapies are available for exudative AMD, with intravitreal anti-VEGF drugs being the most widely used.5
- Open Access
- 7 December 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 29, 101772
Posterior placoid-like maculopathy and macular hole associated with vitamin A deficiency
- 7 December 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 29, 101772
Open AccessPosterior placoid-like maculopathy and macular hole associated with vitamin A deficiency
- Open Access
- 22 October 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (2) , 196-198
The Predictive Value of False-Positive ForeseeHome Alerts in the ALOFT Study
- 22 October 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (2) , 196-198
Open AccessThe Predictive Value of False-Positive ForeseeHome Alerts in the ALOFT Study
- 21 September 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (1) , 92-94
Pneumatic Retinopexy in Dialysis-Associated Rhegmatogenous Retinal Detachments
- 21 September 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (1) , 92-94
Pneumatic Retinopexy in Dialysis-Associated Rhegmatogenous Retinal Detachments
- Open Access
- 1 September 2021
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 23, 101141
Retinoblastoma presenting as pseudohypopyon and preserved visual acuity
- 1 September 2021
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 23, 101141
Open AccessRetinoblastoma presenting as pseudohypopyon and preserved visual acuity
- Open Access
- 31 December 2020
- Published by Digital Journal of Opthalmology in Digital Journal of Ophthalmology
- Vol. 26 (4) , 36-41
Survey of musculoskeletal disorders among US ophthalmologists
PurposeTo characterize the prevalence of work-related musculoskeletal disorders (MSD), symptoms, and risk factors among ophthalmologists.MethodsAn online survey was distributed to ophthalmologist members of the Maryland Society of Eye Physicians and Surgeons. The survey consisted of 34 questions on respondent demographics, practice characteristics, pain, and effects of MSD on their practice patterns. Participants were excluded if they were not ophthalmologists or if they had MSD symptoms prior to the start of their ophthalmology career. Demographics and practice patterns were compared for those with or without MSD symptoms using the Welch t test and the Fisher exact test.ResultsThe survey was completed by 127 of 250 active members (response rate, 51%). Of the 127, 85 (66%) reported experiencing work-related pain, with an average pain level of 4/10. With regard to mean age, height, weight, years in practice, number of patients seen weekly, and hours worked weekly, there was no difference between respondents reporting pain and those without. Those reporting MSD symptoms spent significantly more time in surgery than those who did not (mean of 7.9 vs 5.3 hours/week [P < 0.01]). Fourteen percent of respondents reported plans to retire early due to their symptoms.ConclusionsA majority of respondents experienced work-related MSD symptoms, which was associated with time spent in surgery. Modifications to the workplace environment focusing on ergonomics, particularly in the operating room, may benefit ophthalmologists.
- 31 December 2020
- Published by Digital Journal of Opthalmology in Digital Journal of Ophthalmology
- Vol. 26 (4) , 36-41
Open AccessSurvey of musculoskeletal disorders among US ophthalmologists
PurposeTo characterize the prevalence of work-related musculoskeletal disorders (MSD), symptoms, and risk factors among ophthalmologists.MethodsAn online survey was distributed to ophthalmologist members of the Maryland Society of Eye Physicians and Surgeons. The survey consisted of 34 questions on respondent demographics, practice characteristics, pain, and effects of MSD on their practice patterns. Participants were excluded if they were not ophthalmologists or if they had MSD symptoms prior to the start of their ophthalmology career. Demographics and practice patterns were compared for those with or without MSD symptoms using the Welch t test and the Fisher exact test.ResultsThe survey was completed by 127 of 250 active members (response rate, 51%). Of the 127, 85 (66%) reported experiencing work-related pain, with an average pain level of 4/10. With regard to mean age, height, weight, years in practice, number of patients seen weekly, and hours worked weekly, there was no difference between respondents reporting pain and those without. Those reporting MSD symptoms spent significantly more time in surgery than those who did not (mean of 7.9 vs 5.3 hours/week [P < 0.01]). Fourteen percent of respondents reported plans to retire early due to their symptoms.ConclusionsA majority of respondents experienced work-related MSD symptoms, which was associated with time spent in surgery. Modifications to the workplace environment focusing on ergonomics, particularly in the operating room, may benefit ophthalmologists.
- 1 December 2020
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 51 (12) , 698-705
Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity
BACKGROUND AND OBJECTIVE: To report a series of exudative retinal detachments (ERDs) following laser photocoagulation for retinopathy of prematurity (ROP). PATIENTS AND METHODS: Retrospective case series. RESULTS: Eleven eyes of seven infants were identified who developed ERD following laser. Median gestation age was 25 weeks (interquartile range [IQR]: 24–27 weeks), and median birth weight was 662 grams (IQR: 538–850 grams). Median postmenstrual age at time of laser was 35 weeks (IQR: 33–39 weeks). ERD was diagnosed at a median of 7 days (IQR: 5–7 days) after laser and was managed with steroids. Bevacizumab was also used for certain cases. Time to resolution ranged from 1 to 5 weeks. Macular pigment changes, atrophy, window defect on fluorescein angiography, and photoreceptor loss on optical coherence tomography were noted in some cases following ERD resolution. Excluding one patient who expired at 3 months, median length of follow-up was 10 years (IQR: 9–13.5 years). Overall, only one patient, who presented with less severe ERD, had normal vision. CONCLUSIONS: ERD is an uncommonly reported complication following laser for ROP. Macular changes following ERD resolution may have negative visual consequences. [ Ophthalmic Surg Lasers Imaging Retina . 2020;51:698–705.]
- 1 December 2020
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 51 (12) , 698-705
Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity
BACKGROUND AND OBJECTIVE: To report a series of exudative retinal detachments (ERDs) following laser photocoagulation for retinopathy of prematurity (ROP). PATIENTS AND METHODS: Retrospective case series. RESULTS: Eleven eyes of seven infants were identified who developed ERD following laser. Median gestation age was 25 weeks (interquartile range [IQR]: 24–27 weeks), and median birth weight was 662 grams (IQR: 538–850 grams). Median postmenstrual age at time of laser was 35 weeks (IQR: 33–39 weeks). ERD was diagnosed at a median of 7 days (IQR: 5–7 days) after laser and was managed with steroids. Bevacizumab was also used for certain cases. Time to resolution ranged from 1 to 5 weeks. Macular pigment changes, atrophy, window defect on fluorescein angiography, and photoreceptor loss on optical coherence tomography were noted in some cases following ERD resolution. Excluding one patient who expired at 3 months, median length of follow-up was 10 years (IQR: 9–13.5 years). Overall, only one patient, who presented with less severe ERD, had normal vision. CONCLUSIONS: ERD is an uncommonly reported complication following laser for ROP. Macular changes following ERD resolution may have negative visual consequences. [ Ophthalmic Surg Lasers Imaging Retina . 2020;51:698–705.]
- Open Access
- 5 August 2020
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 7 (3) , 145
Bilateral retinal detachments presenting as manifestations of Vogt-Koyanagi-Harada syndrome
Cite this article as: Schechet SA, Komati R, Hariprasad SM. Bilateral retinal detachments presenting as manifestations of Vogt-Koyanagi-Harada syndrome. Eur J Rheumatol 2020; 7(3): 145.
- 5 August 2020
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 7 (3) , 145
Open AccessBilateral retinal detachments presenting as manifestations of Vogt-Koyanagi-Harada syndrome
Cite this article as: Schechet SA, Komati R, Hariprasad SM. Bilateral retinal detachments presenting as manifestations of Vogt-Koyanagi-Harada syndrome. Eur J Rheumatol 2020; 7(3): 145.